Since PI3K signaling was very heterogeneous in the tested MM cell lines, and the PI3K and mTOR inhibitors displayed fully distinct and different activities across our MM cell lines, we then focused on the downstream-located mTOR signaling. This evidence concerns the gene MTOR and Miyoshi myopathy.